ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Abemaciclib|DRUG: Paclitaxel|DRUG: Letrozole|DRUG: Fulvestrant
Sponsor: MedSIR
Collaborators: Eli Lilly and Company